IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,987,000 | +160.2% | 110,746 | +148.2% | 0.17% | +304.8% |
| Q3 2018 | $2,301,000 | -28.5% | 44,614 | -42.2% | 0.04% | -30.0% |
| Q2 2018 | $3,216,000 | +22.4% | 77,178 | +29.5% | 0.06% | 0.0% |
| Q1 2018 | $2,627,000 | +94.7% | 59,585 | +122.2% | 0.06% | +122.2% |
| Q4 2017 | $1,349,000 | +613.8% | 26,816 | +470.7% | 0.03% | +575.0% |
| Q1 2017 | $189,000 | -48.6% | 4,699 | -53.2% | 0.00% | -50.0% |
| Q3 2016 | $368,000 | -29.0% | 10,032 | -54.9% | 0.01% | -33.3% |
| Q2 2016 | $518,000 | +324.6% | 22,257 | +1026.4% | 0.01% | +500.0% |
| Q4 2015 | $122,000 | – | 1,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |